Patents by Inventor Lance L. Munn

Lance L. Munn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11259714
    Abstract: A system and method is configured for use with an endoscope, a biopsy needle, and a data acquisition system. The system includes a sensor tip and a pressure sensor coupled to the sensor tip and having at least one piezo-resistor component with an internal-facing side and an external-facing side, and an opening adjacent to the at least one piezo-resistor component to allow fluid access to the internal-facing side and the external-facing side. The system also includes a tubing member with a distal end and a proximal end, the sensor tip coupled to the distal end, the sensor tip and the tubing member configured to be routed through the biopsy needle and connection elements coupled to the proximal end of the tubing member, the connection elements configured to mount the tubing member relative to the biopsy needle and to couple the pressure sensor to the data acquisition system.
    Type: Grant
    Filed: May 21, 2014
    Date of Patent: March 1, 2022
    Assignee: The General Hospital Corporation
    Inventors: Gabriel Gruionu, Lucian Gruionu, Lance L. Munn, Rakesh K. Jain
  • Publication number: 20190144867
    Abstract: A method for inhibiting metastasis of cancer cells is provided. Inhibitors of heparan sulfate (HS) or hyaluronic acid (HA) are applied to a tumor or a surgical location after removal of the bulk of the tumor. The inhibitors enzymatically cleave surface HS or HA; genetically modify cancer cells to decrease HS or HA production or interfere with the signaling pathway between HS or HA and a MMP or syndecan.
    Type: Application
    Filed: September 19, 2016
    Publication date: May 16, 2019
    Applicants: Research Foundation of the City University of New York, Memorial Sloan Kettering Cancer Center, The General Hospital Corporation D/B/A Massachusetts General Hospital
    Inventors: John M. TARBELL, Lance L. MUNN, Henry QAZI, Zhongdong SHI
  • Publication number: 20160089043
    Abstract: A system and method is configured for use with an endoscope, a biopsy needle, and a data acquisition system. The system includes a sensor tip and a pressure sensor coupled to the sensor tip and having at least one piezo-resistor component with an internal-facing side and an external-facing side, and an opening adjacent to the at least one piezo-resistor component to allow fluid access to the internal-facing side and the external-facing side. The system also includes a tubing member with a distal end and a proximal end, the sensor tip coupled to the distal end, the sensor tip and the tubing member configured to be routed through the biopsy needle and connection elements coupled to the proximal end of the tubing member, the connection elements configured to mount the tubing member relative to the biopsy needle and to couple the pressure sensor to the data acquisition system.
    Type: Application
    Filed: May 21, 2014
    Publication date: March 31, 2016
    Inventors: Gabriel GRUIONU, Lucian GRUIONU, Lance L. MUNN, Rakesh K. JAIN
  • Publication number: 20090016962
    Abstract: Provided are nanostructures comprising a charged outer surface and an inner core comprising a cancer therapeutic agent or imaging agent, wherein the charged outer surface is selectively removable. Further provided are methods of treating subjects having cell proliferative disorders, e.g., cancer, and kits comprising the above nanostructures.
    Type: Application
    Filed: October 3, 2006
    Publication date: January 15, 2009
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Dai Fukumura, Lance L. Munn, Rakesh K. Jain
  • Patent number: 6010712
    Abstract: A method of treating a condition involving vascular adhesion of cytotoxic white cells by (a) identifying an animal suspected of having a condition involving vascular adhesion of cytotoxic white cells and (b) administering to the animal an amount of bFGF sufficient to decrease cell surface expression of ICAM-I or VCAM-I on endothelial cells, thereby reducing adhesion of cytotoxic white cells to vascular endothelium.
    Type: Grant
    Filed: August 29, 1997
    Date of Patent: January 4, 2000
    Assignees: The General Hospital Corporation, Massachusetts Institute of Technology
    Inventors: Rakesh K. Jain, Robert J. Melder, Gerald C. Koenig, Lance L. Munn